- Home
- Services
- Nanoparticle Functionalization Services
- Nanoparticle Surface Functionalization Services
- Acid Degradable Lipid Nanoparticles
Advanced design and development of acid degradable lipid nanoparticles for pH-triggered intracellular delivery.
Acid degradable lipid nanoparticles are engineered to remain sufficiently stable during preparation, storage, and extracellular transport, while undergoing controlled structural disassembly after exposure to acidic intracellular environments such as endosomes. This design strategy is highly relevant for developers seeking to improve cytosolic delivery efficiency, reduce persistent lipid burden, and achieve more responsive release behavior for nucleic acids, peptides, proteins, and selected small molecules. BOC Sciences provides specialized services for the development of acid degradable lipid nanoparticles, combining rational lipid selection, formulation screening, microfluidic preparation, and physicochemical characterization to help clients build pH-responsive LNP systems with application-focused performance profiles.
Our team supports projects ranging from feasibility studies and early formulation exploration to customized process refinement. For clients building broader lipid nanoparticles for drug delivery strategies, we offer acid-sensitive LNP design as a targeted solution for intracellular release challenges, especially in programs where endosomal processing and carrier clearance are critical formulation considerations.
Acid-Degradable Lipid Nanoparticle MechanismWe provide an integrated service framework for the design, preparation, optimization, and evaluation of acid degradable LNP systems. Our workflows are built to address the core technical questions that matter in pH-responsive lipid carrier development: how to tune degradation behavior, how to preserve encapsulation, how to improve intracellular release, and how to maintain formulation reproducibility.
We support the selection and design of lipid components containing acid-cleavable motifs suitable for pH-responsive nanoparticle construction.
We generate customized acid degradable LNP prototypes tailored to your cargo type, target application, and development stage.
Controlled mixing is often essential for narrowing particle size distribution and improving batch consistency in acid degradable LNP development.
Acid degradable LNPs must achieve both efficient encapsulation and controlled disassembly. We optimize these two requirements together rather than independently.
A defining feature of this platform is its pH-dependent breakdown behavior. We evaluate whether the formulation responds appropriately under acidic conditions while remaining adequately stable at neutral pH.
We characterize the structural and functional parameters needed to understand whether an acid degradable LNP is ready for downstream biological evaluation.
Our service workflows are structured around the main technical levers that determine whether an acid degradable lipid nanoparticle performs as intended. Rather than treating pH responsiveness as an isolated feature, we evaluate how degradability interacts with formulation architecture, payload protection, intracellular release, and analytical readout quality.
From acid-labile lipid selection to triggered release analysis, we help you translate responsive LNP concepts into experimentally actionable formulations.
Acid degradable lipid nanoparticles are especially valuable when project success depends on both efficient carrier assembly and timely intracellular disassembly. We support development programs involving diverse payload classes and use scenarios where controlled acid-triggered behavior can improve functional delivery outcomes.
| Payload or Project Type | Development Focus |
|---|---|
| mRNA Payloads | Optimization of particle assembly, RNA protection, and acid-triggered intracellular release for expression-focused research workflows. Related service support is available through lipid nanoparticles for mRNA delivery. |
| siRNA and Oligonucleotides | Development of pH-responsive LNP systems designed to improve intracellular unpacking and functional nucleic acid delivery while maintaining formulation integrity during handling. |
| Protein and Peptide Cargo | Formulation routes for biologically sensitive macromolecules that benefit from protected transport and triggered intracellular release. |
| Hydrophobic or Amphiphilic Small Molecules | Acid-sensitive LNP systems for compounds requiring lipid-mediated loading combined with environment-responsive release control. |
| Co-Delivery Formulations | Multi-component LNP development for programs investigating simultaneous transport of nucleic acids and secondary functional agents. |
| Targeted Intracellular Delivery Research | Support for projects focused on cytosolic access, endosomal processing, and response-driven nanoparticle disassembly. |
We provide acid degradable lipid nanoparticle design options built around different acid-labile linkers, pH-triggered disassembly behaviors, and intracellular delivery needs. These systems can be tailored for PEG shedding, enhanced endosomal escape, and controlled payload release.
✔ Acetal-Linked Acid Degradable LNPs
These systems contain acetal-based acid-sensitive structures that are generally stable at physiological pH 7.4 but hydrolyze rapidly at pH 5.0–6.5. They are often used to support PEG shedding, endosomal destabilization, and intracellular release of RNA or other sensitive payloads.
✔ Ketal-Based Acid Responsive LNPs
Ketal-containing LNPs maintain structural integrity under near-neutral conditions and cleave faster in acidic endosomal environments. This type is well suited for nucleic acid delivery projects that require efficient payload unpacking and stronger endosomal escape behavior.
✔ Hydrazone-Containing Acid Degradable LNPs
Hydrazone-linked systems usually remain acceptable at neutral pH and become more labile in the pH 5.0–6.0 range. They are useful for formulations designed to trigger cargo release inside endosomal or lysosomal compartments, especially in multifunctional delivery designs.
✔ Imine or Schiff Base Acid Sensitive LNPs
These LNPs use imine-type acid-labile bonds to remain relatively stable during neutral-pH exposure while becoming cleavable under acidic intracellular conditions. They are often explored for pH-triggered surface remodeling and controlled carrier loosening after cellular uptake.
✔ PEG-Sheddable Acid Degradable LNPs
These formulations incorporate acid-cleavable linkers between the PEG segment and lipid anchor. The PEG layer stays attached at pH 7.4 for colloidal stability, then detaches more readily at pH 5.0–6.5, helping enhance membrane interaction and endosomal escape.
✔ Multi-Responsive Custom Acid Degradable LNPs
We also develop custom acid degradable LNP systems with one or more acid-sensitive motifs and tailored lipid compositions. These are suitable for projects needing specific release kinetics or intracellular delivery behavior for mRNA, siRNA, proteins, peptides, or small molecules.
We review your payload type, release objective, and formulation priorities to define an acid-sensitive LNP design strategy and select an appropriate development route.
Multiple compositions and process parameters are screened to identify prototype formulations with suitable particle properties, encapsulation performance, and pH-response behavior.
We evaluate size, PDI, zeta potential, payload incorporation, acid-triggered degradation, and release characteristics to rank and refine candidate formulations.
You receive a structured data package summarizing formulation composition, analytical outcomes, comparative trends, and recommended directions for next-phase optimization.
Challenge: A client's mRNA-LNP formulation showed high encapsulation efficiency (>95%) but exhibited poor protein expression in vitro. Initial mechanistic studies indicated that the majority of the mRNA cargo remained trapped within endosomal compartments after cellular uptake.
Diagnosis: Standard ionizable lipids often rely primarily on protonation-mediated membrane disruption. In this case, the pKa of the formulation was not optimal for triggering robust membrane fusion during the early-to-late endosomal transition (pH 5.5-6.5), leading to lysosomal degradation of the nucleic acid payload.
Solution: Our design team engineered a series of acid-degradable ionizable lipids incorporating pH-sensitive ketal linkers into the hydrophobic tails. During formulation development, we used microfluidic mixing to integrate these lipids into the LNP matrix. These linkers remain stable at physiological pH 7.4 but undergo rapid hydrolysis into more hydrophilic fragments upon entry into the acidic endosomal environment. This sharp physicochemical transition promotes destabilization of the LNP structure, increases local osmotic stress, and enhances endosomal escape more effectively than nondegradable counterparts.
Result: The acid-degradable LNP design achieved a 15-fold increase in cytosolic mRNA delivery efficiency, resulting in a significantly faster and stronger onset of protein expression compared with the benchmark formulation.
Challenge: A research team faced significant systemic toxicity when delivering a potent chemotherapeutic agent via LNPs. The drug leaked prematurely into the bloodstream at physiological pH 7.4, causing off-target damage to healthy tissues before reaching the acidic tumor microenvironment (TME).
Diagnosis: Standard PEG shielding was overly persistent. Although it extended circulation time, it also reduced effective interaction between the particles and tumor cells after arrival at the TME. In addition, the LNP core lacked a triggered release mechanism, resulting in slow and inefficient drug release within the tumor.
Solution: We developed a dual-responsive acid-degradable PEG-lipid shell coupled with a pH-sensitive LNP core. We synthesized a custom DSPE-PEG-hydrazone conjugate that functions as a sheddable corona; the hydrazone bond was designed to cleave selectively in the mildly acidic extracellular tumor environment (pH approximately 6.5). After cleavage, the exposed LNP surface became markedly more fusogenic. We further optimized the internal lipid matrix to incorporate acid-cleavable orthoester cross-linkers, which accelerated particle disassembly only after cellular internalization or within the acidic interstitial space of the TME.
Result: The smart acid-degradable LNPs demonstrated a 4-fold reduction in systemic drug leakage and achieved a 200% improvement in tumor growth inhibition by synchronizing PEG shedding with rapid internal payload release.
Responsive Formulation ExpertiseWe approach acid degradable lipid nanoparticles as engineered delivery systems, not just modified LNPs, with formulation logic built around triggered intracellular behavior.
Integrated Design-to-Testing SupportFrom lipid selection and preparation to characterization and response testing, we provide connected workflows that reduce fragmentation during development.
Application-Oriented OptimizationWe align formulation variables with your payload type and delivery objective rather than applying fixed composition rules across unrelated projects.
Strong Analytical CoverageOur services connect routine LNP measurements with degradation, release, and pH-response evaluation to generate a more complete technical picture.
Flexible Project ScopeWe support exploratory screening, targeted optimization, and broader formulation development efforts for clients working across diverse nanoparticle programs.
Acid Degradable Lipid Nanoparticles are highly valued because they combine delivery stability with triggered intracellular release. For drug developers, this means the carrier can remain sufficiently intact during formulation and transport, then degrade under acidic intracellular conditions to support payload release. This design is especially attractive for nucleic acids and other sensitive therapeutics, as it can improve delivery efficiency, enhance endosomal escape strategies, and create more room for formulation optimization during early-stage development.
Acid-sensitive degradation is important because it helps solve a central challenge in advanced drug delivery: maintaining nanoparticle integrity before uptake while enabling efficient release after cellular internalization. In practice, a well-designed acid-responsive system can improve the balance between encapsulation, particle stability, intracellular trafficking, and cargo liberation. For pharmaceutical developers, this mechanism offers a rational way to engineer delivery systems that are more functional, more tunable, and better aligned with the practical demands of formulation screening and platform development.
Acid Degradable LNPs can improve nucleic acid delivery by supporting several critical steps at once, including encapsulation, cellular uptake, endosomal escape, and intracellular payload release. Their performance depends on coordinated control of lipid structure, ionization behavior, particle size, helper lipid composition, and degradation profile under acidic conditions. At BOC Sciences, we support clients with acid-degradable lipid screening, LNP formulation development, and performance evaluation, helping teams compare formulation strategies more efficiently and identify promising delivery candidates with greater confidence.
The most important parameters typically include acid-triggered degradation behavior, payload compatibility, encapsulation efficiency, nanoparticle size distribution, colloidal stability, surface charge characteristics, and compatibility with helper lipids or other formulation components. Successful development usually depends on how well the chemical design of the lipid matches the functional behavior of the final nanoparticle system. Rather than evaluating one property in isolation, developers should assess how material structure, formulation performance, and application goals interact throughout the development process.
Choosing the right partner involves more than sourcing a lipid material. Drug developers often look for a provider that can support the full workflow, from lipid design and nanoparticle preparation to physicochemical characterization and application-focused evaluation. For Acid Degradable Lipid Nanoparticles, this integrated capability is particularly important because material chemistry and formulation behavior are tightly linked. BOC Sciences offers end-to-end support for acid-sensitive lipid and LNP development, helping clients build efficient research paths and make better-informed formulation decisions.